SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Dec 19, 2014
Document Date
Dec 19, 2014
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com